A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
Trial details
- Registry ID
- NCT06674577
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptNCT06674577 | VERA | Phase 2 | Enrolling by invitation | 2031-05-21Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |